Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
13,697 total articles
TeraWulf's 20-year, $19B lease with Anthropic and the 401 MW Justified Data campus materially shift the company's revenue profile from bitcoin mining to utility-grade AI hosting. The market has priced some of that transition already; I propose a long trade with a strict stop to capture re-rating while limiting downside from execution risk and negat…
Oracle (ORCL) is trading near $137 after a sharp derating from last year's highs. The company still generates strong profitability (ROE ~28%), trades at a mid-teens EV/EBITDA and a P/E of ~22, and sits on strategic AI and renewable-energy initiatives. Negative free cash flow and leverage are valid concerns, but the current price embeds pessimism th…
Generate Biomedicines (GENB) is a clinical-stage generative biology company whose platform aims to design biologics with improved durability and dosing intervals. The stock trades at $13.86 with a $1.78B market cap after a summer run; we believe the market undervalues the commercial premium that longer dosing could command. This trade idea outlines…
Baxter (BAX) has momentum after a strong Q2 print, but the operational disruption and costs tied to the Vantive transition complicate a clear path back to healthy margins. With negative EPS, meaningful leverage and EV/EBITDA above 19x, this is a tactical short against uneven profitability and execution risk. Entry $25.05, stop $28.00, first target …
UroGen is transitioning into a commercial-growth biotech driven by strong Zusduri uptake and stable Jelmyto sales. The stock trades at a high revenue multiple, but near-term revenue cadence and upcoming pipeline readouts create a defined risk/reward for a 180-trading-day trade.
Celsius trades at $28.55 with a $7.18B market cap but generates meaningful free cash flow. Recent suits tied to the Alani Nu brand created a headline-driven selloff. If management executes product reforms and marketing discipline, CELH can regain investor confidence and move materially higher over the next 180 trading days.
Grupo Financiero Galicia (GGAL) looks attractively short right now. Argentina macro volatility, peso sensitivity, and bank-sector risk make a full-throttle recovery unlikely in the next 2-3 months. I prefer a tactical short with strict risk control and a mid-term horizon while watching for stabilization signals that would invalidate the thesis.
Quanta Services (PWR) looks positioned for another leg higher as a record $53.4B backlog and a hyper-growth Technology & Load Centers business (projected +220% to +240% in 2026) push revenue and margin upside. The stock trades at a premium – P/E ~79 and EV/EBITDA ~36.5 – but strong free cash flow ($2.29B trailing) and healthy fundamentals back a tr…
Sana’s fusogen and engineered-cell platform has real scientific milestones and recent partnership momentum. At a $784M market cap and an oversold technical setup, a disciplined long-sized trade can pay off if upcoming collaborations or preclinical readouts push sentiment; downside is large and binary — treat this as a high-risk, event-driven swing.
Marathon Digital (MARA) trades like a busted growth stock while still owning an operating bitcoin-mining machine with tangible production and balance-sheet optionality. The market cap of ~$3.65B and enterprise value of ~$5.65B imply steep discounts to any recovery scenario, but the company carries meaningful leverage, negative cash flow and near-te…
Rigetti is a small but increasingly strategic player in quantum computing. The stock is volatile and richly valued on headline metrics, but recent revenue acceleration, CHIPS Act support and concrete technical roadmaps (chip redesigns to tackle coherence) create a buy-and-hold opportunity for investors who can stomach loss-making, capital-intensive…
Granite Ridge Resources (GRNT) is trading at income-like yields and cheap valuation metrics, but lease operating expenses are compressing margins and cash flow. We present a high-conviction swing short: entry $4.80, target $4.10, stop $5.20 over a 45-trading-day window, with clear catalysts and downside risks framed.
Broadcom's position as a dominant AI-infrastructure supplier faces headwinds as large customers like Google increase in-house chip design. That dynamic makes further M&A and software monetization likelier. Given Broadcom's cash flow, balance sheet and premium multiple, a disciplined long with a defined stop and 180-day horizon offers asymmetric ups…
Marvell is sitting on what looks like a multi-year AI infrastructure growth wave — optical interconnects, PCIe signal conditioning and custom data-center silicon — that the market hasn't fully priced in. The company has strong fundamentals, double-digit returns on equity, and a clear hyperscaler roadmap. This trade idea lays out a pragmatic long en…
Rolls-Royce has fallen since my prior downgrade but a set of persistent margin risks, order timing uncertainty and cash-cycle issues argue for a tactical short. I lay out an entry at $5.00, a stop at $5.70 and a mid-term target of $3.20 (45 trading days) with a longer target of $2.60 (180 trading days) if headwinds persist.
BWX Technologies delivers predictable, defense-backed cash flows while incremental commercial growth (TRISO fuel, uranium processing, medical isotopes) can re-rate the multiple. We upgrade to Buy and lay out an actionable entry at $139.86, stop at $125.00 and a $170.00 target over a 180-trading-day position.
Hims & Hers (HIMS) is a telehealth growth story with a checkered regulatory moment. The stock is trading around $30.65 with a $7.15B market cap, modest free cash flow, and heavy short interest. Regulatory headlines have driven outsized moves, creating a tradeable setup where a defined entry, tight stop and realistic target offer asymmetric reward-t…
Stryker's operational momentum from a Q2 recovery, coupled with ongoing portfolio expansion and structural leverage in its surgical and orthopedics franchises, supports a mid‑term long trade. The thesis rests on procedure volume normalization, improving margins as mix shifts to higher‑value procedures, and multiple near‑term catalysts that can re‑r…
This trade idea recommends a tactical long in gold (XAUUSD) arguing that a combination of persistent fiscal stress and deliberate inflationary policy - a soft debt default - will push real yields lower and lift gold. Entry, stop, and targets provided with a 180 trading day horizon and clear risk controls.
Lumentum (LITE) plunged after a broad AI-infrastructure puke on 10/12/2026, but fundamentals show durable free cash flow, manageable leverage, and a backlog narrative that could re-rate the stock if revenue converts. This trade targets a rebound to prior highs while keeping downside risk tightly controlled.
Johnson Controls is finally reaping the benefits of deliberate investments in the 'hard parts' of cooling - compressors, industrial refrigeration and data-center systems - and that is showing up in backlog, margin resilience and cash generation. The shares are trading near $155 with a valuation that prices solid execution; this trade buys into ongo…
Palomar's focused exposure to earthquake-exposed states, accelerating gross written premiums and improving profitability make it a compelling mid-term long trade. Combine a reasonable P/E (~17.4), strong free cash flow and a thin float with bullish technicals and you have a risk/reward setup that favors a move toward $160 over the next 45 trading d…
TLT yields look decent on paper - the 30-day SEC yield is 5.55% and distribution yield is about 5.0% - but the price still carries meaningful duration risk. Given the technical downtrend, compressed yield premium to bill ETFs, and a sloppy macro backdrop for long-duration Treasuries, this is a tactical short trade for a mid-term horizon (45 trading…
Lam Research (LRCX) slides from recent highs have created a mid-term buying opportunity. The company’s FY27 setup - robust demand from AI-related chip builds, heavy free cash flow generation, and a conservative balance sheet - supports a long trade into Q1 results. Enter at $310.00, stop at $285.00, target $360.00 for a mid-term (45 trading days) s…
Satellogic is a vertically integrated Earth-observation company trading at roughly $4.70 with a market cap near $723M. Recent defense wins, an executive hire with NGA pedigree, and an exclusive maritime channel for the upcoming Merlin constellation make the story interesting. But the stock carries a rich valuation, negative earnings, and execution …
